1. Cost Of Heart Failure Management In Turkey: Results Of A Delphi Panel
- Author
-
Dursun Aras, Engin Bozkurt, Mehmet Eren, Yuksel Cavusoglu, Zeki Öngen, Mete Saylan, Pınar Kızılırmak, Sinan Aydoğdu, Mehmet Yilmaz, Çetin Erol, Lale Tokgozoglu, Sadi Gulec, Oktay Özdemir, Ekrem Yeter, Kardiyoloji, Zonguldak Bülent Ecevit Üniversitesi, [Aras, Dursun -- Aydogdu, Sinan] Karabuk Univ, Fac Med, Dept Cardiol, Zonguldak, Turkey -- [Bozkurt, Engin -- Yeter, Ekrem] Yildirim Beyazit Univ, Fac Med, Dept Cardiol, Ankara, Turkey -- [Cavusoglu, Yuksel] Eskisehir Osmangazi Univ, Fac Med, Dept Cardiol, Eskisehir, Turkey -- [Eren, Mehmet] Siyami Ersek Cardiovasc Surg Training & Res Hosp, Dept Cardiol, Istanbul, Turkey -- [Erol, Cetin -- Gulec, Sadi] Ankara Univ, Fac Med, Dept Cardiol, Ankara, Turkey -- [Kizilirmak, Pinar -- Saylan, Mete] Novartis, Med Dept, Istanbul, Turkey -- [Ongen, Zeki] Istanbul Univ, Cerrahpasa Fac Med, Dept Cardiol, Istanbul, Turkey -- [Ozdemir, Oktay] Yorum Consulting Ltd, Dept Stat, Istanbul, Turkey -- [Tokgozoglu, Lale] Hacettepe Univ, Fac Med, Dept Cardiol, Ankara, Turkey -- [Yilmaz, Mehmet Birhan] Cumhuriyet Univ, Fac Med, Dept Cardiol, Sivas, Turkey, YILMAZ, MEHMET BIRHAN -- 0000-0002-8169-8628, YILMAZ, Mehmet Birhan -- 0000-0002-8169-8628, and Erol, Cetin -- 0000-0001-7396-3818
- Subjects
Adult ,Male ,medicine.medical_specialty ,Turkey ,Psychological intervention ,Delphi method ,MEDLINE ,heart failure ,Disease ,030204 cardiovascular system & hematology ,Delphi ,New york heart association ,03 medical and health sciences ,0302 clinical medicine ,Environmental protection ,Surveys and Questionnaires ,cost ,medicine ,Humans ,030212 general & internal medicine ,Aged ,Ejection fraction ,business.industry ,Hot Topic ,Health Care Costs ,Middle Aged ,medicine.disease ,Coronary heart disease ,Heart failure ,Emergency medicine ,economic burden ,Cardiology and Cardiovascular Medicine ,business - Abstract
WOS: 000384427500003, PubMed ID: 27515102, Objective: To analyze health-related cost of heart failure (HF) and to evaluate health-related source utilization aiming to provide data on the economic burden of HF in actual clinical practice in Turkey. Methods: The study used the Delphi process of seeking expert consensus of opinion including 11 cardiologists who are experienced in HF. The standardized questionnaire comprised items to reflect the opinion of the expert panelists on the distribution of the HF patients in terms of demographic and clinical characteristics and background disease states. Costs related to out-patient follow-up, in-patient follow-up, medications, and other therapies were also evaluated. Results: 34.1% of the HF patients were in the age range of 60-69 years, and 62.3% were males. Coronary heart disease was the leading cause of HF (59.6%); 63.6% of the HF patients had reduced ejection fraction (rEF) and 42.3% were in New York Heart Association (NYHA)-II class. Approximately 75 % of the patients were followed up by a cardiology unit. The total annual visit number was estimated as 3.41. Approximately 32% of HF patients were hospitalized 1.64 times a year, for an average of 6.77 days each time. The total annual costs of all HF patients and HF-rEF patients were estimated as 1.537 TL and as 2.141 TL, respectively. Conclusion: The analysis demonstrating the magnitude of the economic impact of HF management on Turkey's healthcare system may help facilitate health and social policy interventions to improve the prevention and treatment of HF.
- Published
- 2016